CIK 0001626878
- Non-accelerated filer
- Smaller reporting company
XBiotech Inc.
Sign in to watch- Ticker
- XBIT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 512-386-2900
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- Open-market buys, last 90 days
- $854,660
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$854,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-07 | RENNES FONDATION 10% owner | Purchase | +40,000 | $10.00 | $400K | 3,698,282 |
| 2019-02-06 | RENNES FONDATION 10% owner | Purchase | +35,000 | $8.93 | $313K | 3,628,282 |
| 2019-02-06 | RENNES FONDATION 10% owner | Purchase | +30,000 | $9.49 | $285K | 3,658,282 |
| 2019-01-04 | SHIVASWAMY SUSHMA Chief Scientific Officer | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2019-01-04 | HAN QUEENA VP Finance & HR | Grant or award · Stock Option | +25,000 | 25,000 | ||
| 2019-01-02 | RENNES FONDATION 10% owner | Purchase | +900 | $5.15 | $5K | 3,593,282 |
| 2018-12-27 | MCKENZIE W THORPE Director | Purchase | +1,364 | $4.92 | $7K | 47,738 |
| 2018-12-27 | RENNES FONDATION 10% owner | Purchase | +2,200 | $4.98 | $11K | 3,592,382 |
| 2018-12-27 | MCKENZIE W THORPE Director | Purchase | +1,364 | $4.92 | $7K | 32,702 |
| 2018-12-26 | MCKENZIE W THORPE Director | Purchase | +18,636 | $5.07 | $95K | 46,374 |
| 2018-12-26 | MCKENZIE W THORPE Director | Purchase | +3,600 | $5.00 | $18K | 31,338 |
| 2018-12-24 | MCKENZIE W THORPE Director | Purchase | +24,838 | $5.88 | $146K | 27,738 |
| 2018-12-24 | MCKENZIE W THORPE Director | Purchase | +24,838 | $5.88 | $146K | 27,738 |
| 2018-12-21 | RENNES FONDATION 10% owner | Purchase | +4,200 | $6.24 | $26K | 3,590,182 |
| 2018-12-19 | SIMARD JOHN Chief Executive Officer | Option exercise | +50,000 | $2.50 | $125K | 6,327,060 |
| 2018-12-19 | SIMARD JOHN Chief Executive Officer | Option exercise · Stock Option | −50,000 | 0 | ||
| 2018-11-12 | MCKENZIE W THORPE Director | Purchase | +700 | $3.75 | $3K | 2,900 |
| 2018-11-09 | MCKENZIE W THORPE Director | Purchase | +2,200 | $3.74 | $8K | 2,200 |
| 2018-10-04 | MCKENZIE W THORPE Director | Sale | −385,000 | $3.00 | $1.2M | 3,398,600 |
| 2018-09-26 | MCKENZIE W THORPE Director | Sale | −17,634 | $3.05 | $54K | 3,783,600 |
Page 8 of 14 · 273 trades